Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study
2020 P. Lampertico, T. Berg, M. Buti, A. Pathil, J. Petersen, S.D. Ryder, F. Zoulim, I. Botros, J.F. Flaherty, B. Jump, M.L. Op den Brouw, A. van Troostenburg, H. Ramroth, M. Bourliere, V. De Ledinghen, G. Riachi, F. Zoulim, V. Loustaud-Ratti, A. Tran, D. Larrey, J. Dumortier, V. Leroy, S. Metivier, P. Sellier, S. Mauss, J. Peterson, T. Berg, I. Schiefke, C. Niederau, G. Teuber, T. Goeser, M.C. Jung, A. Grambihler, A. Pathil-Warth, K. Sprinzl, M. Von der Ohe, C. Antoni, K. Weigand, P. Andreone, P. Lampertico, V. Di Marco, S. Madonia, M. Puoti, T. Santantonio, M. Vigano, A. Ciancio, G. D'Offizi, M. Pirisi, M. Buti, E. Suarez Garcia, J.M. Pascasio Acevedo, R. Andrade, F. Gea, M.A. Serra Desfilis, E. Molina Perez, M. Manzano Alonso, J.A. Carrion, S. Aoufi Rabih, M.M. Planas, S. Ryder, K. Agarwal, A. Ustianowski, R. Aspinall, P. Kennedy, A.M. Geretti, R. Mccorry, M. Foxton, B. Healy